Re: Why has Palantir been given an interim contract to work on an NHS patient data project?

The letter expresses concerns about the potential consequences of linking NHS patient data with commercial interests, such as privacy breaches. It highlights Iceland’s experience of a failed health data commercialisation attempt as a cautionary tale. The author suggests that if a similar approach is adopted in the UK, many may opt out, placing the biotech industry at risk.